Evaluation and Treatment of Elevated FSH and LH in Males
Elevated FSH and LH in males indicates primary testicular failure, requiring immediate evaluation with semen analysis, testosterone measurement, and genetic testing to determine the extent of spermatogenic dysfunction and guide fertility preservation strategies. 1
Understanding the Hormonal Pattern
The combination of elevated FSH and LH with low or low-normal testosterone represents primary testicular dysfunction (hypergonadotropic hypogonadism), where the pituitary gland increases gonadotropin output in response to inadequate testicular function. 1, 2 This differs fundamentally from secondary hypogonadism, where FSH and LH would be low or inappropriately normal. 2
- FSH >7.6 IU/L strongly suggests non-obstructive azoospermia or severe oligospermia with primary testicular dysfunction, though this threshold is lower than many laboratory reference ranges. 1, 3
- Men with FSH >7.5 IU/L have a five- to thirteen-fold higher risk of abnormal sperm concentration compared to men with FSH <2.8 IU/L. 3
- The degree of FSH elevation correlates with severity of spermatogenic failure, with FSH levels negatively correlated with the number of spermatogonia. 1
Immediate Diagnostic Workup
Essential Laboratory Tests
- Obtain at least two semen analyses separated by 2-3 months after centrifugation to confirm azoospermia or determine the degree of oligospermia, as single analyses can be misleading due to natural variability. 1
- Measure total testosterone, LH, and SHBG to calculate free testosterone and fully characterize the hypothalamic-pituitary-testicular axis. 1, 2
- Check serum prolactin to exclude hyperprolactinemia, which can disrupt gonadotropin secretion. 1
- Assess thyroid function (TSH, free T4) as thyroid disorders commonly affect reproductive hormones and can cause reversible FSH elevation. 1
Mandatory Genetic Testing
If sperm concentration is <5 million/mL or azoospermia is confirmed:
- Karyotype analysis to exclude Klinefelter syndrome (47,XXY) and other chromosomal abnormalities. 1
- Y-chromosome microdeletion testing (AZFa, AZFb, AZFc regions) is mandatory, as complete AZFa and AZFb deletions predict near-zero sperm retrieval success and contraindicate testicular sperm extraction. 1
Physical Examination Priorities
- Measure testicular volume using Prader orchidometer—volumes <12 mL indicate testicular atrophy and increased risk for progressive spermatogenic decline. 1
- Evaluate for varicocele on standing examination, as repair can improve fertility in men with clinical varicoceles and abnormal semen parameters. 1
- Assess testicular consistency and examine for vas deferens/epididymal abnormalities. 1
Addressing Reversible Causes
Before concluding that testicular dysfunction is permanent, systematically evaluate and correct potentially reversible factors:
- Thyroid dysfunction can disrupt the hypothalamic-pituitary-gonadal axis and should be corrected before making definitive fertility assessments. 1
- Metabolic optimization: Weight loss and achieving BMI <25 can normalize gonadotropins and improve testosterone levels in obesity-associated dysfunction. 1, 2
- Medication review: Discontinue any drugs affecting the hypothalamic-pituitary-gonadal axis. 2
- Recheck hormones after 3-6 months of metabolic optimization to determine if FSH elevation was partially reversible. 1
Critical Treatment Pitfalls to Avoid
Never Prescribe Exogenous Testosterone if Fertility is Desired
Exogenous testosterone completely suppresses spermatogenesis through negative feedback on the hypothalamus and pituitary, causing azoospermia that can take months to years to recover. 1, 2 This is the single most important contraindication in men with elevated FSH who desire fertility.
Fertility Preservation Strategy
Immediate Sperm Banking
Men with elevated FSH and any detectable sperm should immediately cryopreserve sperm, banking 2-3 separate ejaculates before any intervention. 1 This provides insurance against:
- Progressive spermatogenic failure
- Technical failures or poor post-thaw recovery
- Need for multiple assisted reproductive technology attempts
Once azoospermia develops, even microsurgical testicular sperm extraction (micro-TESE) only achieves 40-50% sperm retrieval rates. 1
Treatment Options Based on Sperm Status
For Men with Oligospermia (Low but Detectable Sperm)
- Varicocele repair should be strongly considered if a clinical (palpable) varicocele is present, as correction improves semen quality and fertility rates, with 31% achieving pregnancies leading to live births. 1
- Assisted reproductive technology (IVF/ICSI) offers superior pregnancy rates compared to empiric hormonal therapy and should be discussed early, especially considering female partner age. 1
- Off-label hormonal treatments (selective estrogen receptor modulators, aromatase inhibitors) have limited benefits that are outweighed by ART advantages. 1
For Men with Non-Obstructive Azoospermia
- Microsurgical testicular sperm extraction (micro-TESE) is the gold standard, achieving sperm retrieval in 40-60% of cases despite elevated FSH. 1
- Micro-TESE is 1.5 times more successful than conventional TESE and causes less testosterone suppression. 1
- Complete AZFa and AZFb deletions contraindicate TESE due to near-zero retrieval likelihood. 1
- AZFc deletions have variable presentation, with successful sperm retrieval in 53-75% of cases. 1
Special Consideration: Distinguishing from Secondary Hypogonadism
If both FSH and LH are low or inappropriately normal (not elevated) with low testosterone, this indicates hypogonadotropic hypogonadism rather than primary testicular failure. 2 In this scenario:
- Gonadotropin therapy with hCG initially, followed by FSH addition after testosterone normalization, can successfully initiate spermatogenesis in 75% of men. 1, 2
- This represents a fundamentally different and more treatable condition than primary testicular failure. 2
Long-Term Health Implications
Men with abnormal semen parameters and elevated FSH have:
- Higher rates of testicular cancer compared to fertile men. 1
- Increased mortality rates and more comorbidities compared to fertile controls. 1, 4
- Increased risk of osteoporosis, metabolic syndrome, and cardiovascular disease related to hypogonadism. 4
This makes comprehensive health screening important beyond fertility concerns alone. 1, 4
Monitoring Protocol
- Repeat semen analysis every 3-6 months to establish whether parameters are stable or declining. 1
- Recheck FSH, LH, testosterone, and thyroid function after metabolic optimization. 1
- Consider sperm cryopreservation if follow-up shows declining sperm concentration, especially if approaching 5 million/mL. 1